Pfizer
AstraZeneca completes respiratory deal with Almirall
November 3, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory
AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …
Google X developing diagnosis pill
October 29, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables
Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …
GSK mulls $27 billion ViiV sell-off
October 23, 2014Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV
After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …
Pfizer breast cancer pill gets FDA nod
October 14, 2014Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …
ABPI and BIA establish new manufacturing partnership
September 23, 2014Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip
The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …
Pfizer partners with MedGenesis on Parkinson’s
September 16, 2014Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience
Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
Bristol-Myers Squibb: following the string of pearls
September 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions
Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …
AZ shares climb on positive cancer drug news
September 1, 2014Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1
AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …
Asterias Biotherapeutics adds two to board
August 26, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asterias Biotherapeutics, Pfizer
US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …
Pfizer/BMS blood thinner gains new licence
August 22, 2014Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin
Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …
AstraZeneca shores up defences against Pfizer
August 22, 2014Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger
AstraZeneca has been making a series of big deals over the past three months as it looks to close the …
Pfizer teams up with Google-backed 23andMe
August 13, 2014Research and Development, Sales and Marketing 23andME, Crohn’s disease, Pfizer, google, ulcerative colitis
Pfizer and genetics testing firm 23andMe have come together in a research pact aimed at finding the genetic cause of …
AbbVie/Shire deal under threat from tax laws
August 7, 2014Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion
The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …
ABPI president: NICE needs political reform
August 1, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, NICE, Pfizer, jonathan emms, vba
Jonathan Emms, the new president of the ABPI, is a man not shy about defending the rights of the UK …
Boehringer’s Striverdi gains FDA approval
August 1, 2014Sales and Marketing Advair, COPD, Pfizer, Spiriva, asthma, olodaterol
Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
